Tag: Baroness Brinton

  • Baroness Brinton – 2016 Parliamentary Question to the Department of Health

    Baroness Brinton – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Baroness Brinton on 2015-12-22.

    To ask Her Majesty’s Government which organisation has responsibility for ensuring implementation and compliance with the Medicines and Healthcare products Regulatory Agency guidance, which states that biologic medicines should be prescribed by brand name and tracked by batch number.

    Lord Prior of Brampton

    In 2008, the Medicines and Healthcare products Regulatory Agency (MHRA) issued best practice guidance on the prescribing of biological products. This advised:

    “All biosimilar products are prescription only medicines (POM). When prescribing biological products, it is good practice to use the brand name. This will ensure that automatic substitution of a biosimilar product does not occur when the medicine is dispensed by the pharmacist. Products (biosimilar and reference) that have the same international non-proprietary name (INN) are not to be presumed identical for the reasons given above.”

    The MHRA does not have responsibility for monitoring the compliance of healthcare professionals with its prescribing guidance. The responsibility for prescribing rests with the practitioner who has clinical responsibility for their patient’s care and we would expect practitioners to take any relevant guidance into account when making their prescribing decisions. Practitioner professional bodies also have a role in setting out best practice to their members.

  • Baroness Brinton – 2016 Parliamentary Question to the Department of Health

    Baroness Brinton – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Baroness Brinton on 2015-12-22.

    To ask Her Majesty’s Government which organisation has responsibility for ensuring compliance with EU legislation on pharmacovigilance.

    Lord Prior of Brampton

    The Medicines and Healthcare products Regulatory Agency has the responsibility for ensuring compliance with European Union legislation on pharmacovigilance.

  • Baroness Brinton – 2014 Parliamentary Question to the Foreign and Commonwealth Office

    Baroness Brinton – 2014 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Baroness Brinton on 2014-06-17.

    To ask Her Majesty’s Government what representations they have made to the government of Sri Lanka about the attacks on Muslims on 15 June by Buddhists in Aluthgama; and what information have they received from the government of Sri Lanka about its plans to halt the sectarian violence.

    Baroness Warsi

    We continue to raise our concerns about the recent communal tensions and the significant surge in attacks against members of religious minority groups in Sri Lanka including those of 15 June, with the Sri Lankan authorities. Our High Commissioner to Colombo has met Muslim community representatives to discuss their concerns. The Head of the EU Delegation has raised recent developments with the Sri Lankan Defence Secretary. The EU delegation has released a statement in agreement with EU Heads of Mission in Sri Lanka condemning the violence and have called on the Sri Lankan government to uphold law and order.

    Sri Lankan President Rajapaksa and other senior Sri Lankan Ministers have visited the area affected by violence, and the army and police have been deployed to those areas. President Rajapaksa has also urged restraint and pledged that those responsible for the violence would be held to account. We continue to watch the situation closely.